tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
PremiumRatingsRein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
3M ago
Rein Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Rein Therapeutics Reports Q3 2025 Financial Results
3M ago
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
Premium
Ratings
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
4M ago
Rein Therapeutics Secures Third Pre-Paid Advance
PremiumCompany AnnouncementsRein Therapeutics Secures Third Pre-Paid Advance
4M ago
Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03
Premium
The Fly
Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03
5M ago
Rein Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Rein Therapeutics initiated with a Buy at H.C. Wainwright
5M ago
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
PremiumThe FlyPalo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
6M ago
Rein Therapeutics Gains Approval for Phase 2 Trial
Premium
Company Announcements
Rein Therapeutics Gains Approval for Phase 2 Trial
6M ago
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
Premium
The Fly
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100